120 results
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
(or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto
D
HEPA
Hepion Pharmaceuticals Inc
3 Oct 23
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
5:22pm
, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials … under this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
materials, including the exhibits thereto and documents incorporated by reference therein, together with the Registration Statement, Prospectus … (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage
424B5
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Prospectus supplement for primary offering
4:52pm
maintain a website at www.hepionpharma.com, at which you may access these materials free of charge as soon as reasonably practicable after
8-K
4c8 g9dzv6r4os
24 Jul 23
Regulation FD Disclosure
4:04pm
8-K
EX-1.1
mxrh smppl
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
424B5
2vou1r3g 8vc64m
21 Jul 23
Prospectus supplement for primary offering
4:39pm
8-K
513f2whe3wu
22 May 23
Regulation FD Disclosure
1:05pm
DEFA14A
o55 bg45186z68zte3r
28 Apr 23
Additional proxy soliciting materials
4:44pm
D
hckt5k4ch6zq5sqb
15 Nov 22
$20.00 mm in equity, sold $20.00 mm, 8 investors
4:14pm
8-K
EX-10.1
3uo4zbn
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
EX-10.2
zom5hcowy1z
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
xq132uddxwc0e5yfjgav
17 Oct 22
Regulation FD Disclosure
5:13pm
DEFA14A
9ea6xs9 tnhgugkg3m8
26 Jul 22
Additional proxy soliciting materials
4:05pm
DEFA14A
htrjsizop1hsa0fo
22 Jul 22
Additional proxy soliciting materials
9:31pm